See how science, strategy, and innovation are transforming the GLP-1 space: #GLP1 #oralGLP1 #metabolichealth #diabetescare #obesity #obesitytreatment #pharmainnovation #futureproofingbusinesses #IeB To view or add a comment, sign in #MIMSPharmaMarketInsightUpdate, September 2025 Including: SGLT2 inhibitors should be offered first-line to people with heart failure with reduced ejection fraction A new formulation of Rybelsus (semaglutide) tablets has been released The first inhaled levodopa product, Inbrija (levodopa), has been launched
Tesofensine's efficacy extends to boosting cognitive function, enhancing mood, and potentially improving blood sugar regulation
Most of the clinical literature supporting the molecules covered here was generated using either topical-only application or in-office injection or microneedling
Niacinamide: Dermal delivery strategies and clinical applications
It violates FTC guidelines and suggests a company willing to deceive consumers in its marketing, which raises questions about what else might be misrepresented
Carnitine is literally my favourite amino and the most beneficial fat burner for me because it mobilised fat into the body which I can then burn off through hard work in the gym
